Skip to main content

Table 2 The cumulative incidence rates of early transplant-related mortality after allogeneic hematopoietic cell transplantation

From: Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia

Variables

Total

Number of early TRM (%)

Within 50 days

p-value

Within 100 days

p-value

Total

5395

151 (2.9)

 

442 (8.3)

 

Year of transplantation

 2003–2009

1958

47 (2.4)

0.210

160 (8.2)

1.000

 2010–2015

3437

104 (3.0)

 

282 (8.2)

 

Recipient age, years

 Mean

35.9 ± 16.6

39.1 ± 16.3

0.017

38.0 ± 16.9

0.005

 0–19

1145

22 (1.9)

0.164

76 (6.6)

0.015

 20–39

1707

47 (2.8)

 

127 (7.4)

 

 40–59

2229

73 (3.3)

 

213 (9.6)

 

  ≥ 60

314

9 (2.9)

 

26 (8.3)

 

Recipient sex

 Male

2973

69 (2.3)

0.023

239 (8.0)

0.685

 Female

2422

82 (3.4)

 

203 (8.4)

 

Diagnosis

 ALL

1905

65 (3.4)

0.054

179 (9.4)

0.020

 AML

3490

86 (2.5)

 

263 (7.5)

 

Time from diagnosis to transplantation, months

  < 9

4434

93 (2.1)

< 0.001

315 (7.1)

< 0.001

  ≥ 9

961

58 (6.0)

 

127 (13.2)

 

Previous transplantations

 No

5064

120 (2.4)

< 0.001

385 (7.6)

< 0.001

 Yes

331

31 (9.4)

 

57 (17.2)

 

Previous iron chelation therapy

 No

4602

149 (3.2)

< 0.001

428 (9.3)

< 0.001

 Yes

793

2 (0.3)

 

14 (1.8)

 

Graft source

 Peripheral blood

4041

119 (2.9)

< 0.001

333 (8.2)

< 0.001

 Bone marrow

1141

19 (1.7)

 

70 (6.1)

 

 Cord blood

213

13 (6.1)

 

39 (18.3)

 

Use of ATG

 No

3061

77 (2.5)

0.173

229 (7.5)

0.033

 Yes

2334

74 (3.2)

 

213 (9.1)

 
  1. TRM Transplant-related mortality; ALL Acute lymphocytic leukemia; AML Acute myeloid leukemia; ATG Antithymocyte globulin
  2. Values are presented as means ± standard deviations or numbers of cases (%)